Pemphigus

Showing 1 - 20 of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Recruiting
  • Inherited Epidermolysis Bullosa
  • +8 more
    • Bobigny, France
    • +14 more
    Jul 18, 2023

    Pemphigus, Dermatologic Disease Trial (RiTUXimab Injection)

    Not yet recruiting
    • Pemphigus
    • Dermatologic Disease
    • RiTUXimab Injection
    • (no location specified)
    Jun 7, 2023

    5-Point Investigator Global Assessments for Pemphigus

    Recruiting
    • Pemphigus
    • Investigator Global Assessments (IGAs)
    • Kogarah, New South Wales, Australia
    • +6 more
    Sep 16, 2022

    Human Leukocyte Antigen Class II Alleles and Haplotypes

    Recruiting
    • Pemphigus
    • +3 more
    • A single blood sample for HLA typing
    • Moscow, Russian Federation
      Sechenov University
    Mar 10, 2022

    Proteasomes inDermatological Autoimmune Disease: Bullous

    Terminated
    • Pemphigoid, Bullous
    • +2 more
      • Nîmes Cedex 09, France
        CHU de Nîmes - Hôpital Universitaire Carémeau
      May 4, 2018

      Pemphigus Trial in United States (Infliximab, Placebo Comparator)

      Completed
      • Pemphigus
      • Los Angeles, California
      • +3 more
      Nov 1, 2017

      Pemphigus, Dermatological Disease Trial in France (psychological support and therapeutic education program)

      Unknown status
      • Pemphigus
      • Dermatological Disease
      • psychological support and therapeutic education program
      • Bobigny, France
      • +8 more
      Aug 29, 2017

      Pemphigus Trial in Irvine (Sirolimus (formerly known as Rapamycin))

      Terminated
      • Pemphigus
      • Sirolimus (formerly known as Rapamycin)
      • Irvine, California
        University of California, Irvine
      May 8, 2017

      Pemphigus Trial in Luebeck (Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine)

      Completed
      • Pemphigus
      • Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
      • Luebeck, Schleswig-Holstein, Germany
        Department of Dermatology, University of Luebeck
      Jan 31, 2017

      Pemphigus, Pemphigoid Trial in Mexico (Cotton gauze with petrolatum, Cellulose acetate with petrolatum, Nanocrystalline silver

      Unknown status
      • Pemphigus
      • Pemphigoid
      • Cotton gauze with petrolatum
      • +3 more
      • Mexico, DF, Mexico
      • +1 more
      Feb 18, 2015

      Pemphigus Trial in Chandigarh (Rituximab and Cyclophosphamide IV)

      Unknown status
      • Pemphigus
      • Rituximab and Cyclophosphamide IV
      • Chandigarh, India
      • +1 more
      Oct 29, 2014

      Pemphigus Trial in Rouen (Mabthera)

      Completed
      • Pemphigus
      • Rouen, Seine maritime, France
        UH-Rouen
      Jun 17, 2013

      Pemphigus Trial in Chicago (Hematopoietic stem cell transplantation)

      Terminated
      • Pemphigus
      • Hematopoietic stem cell transplantation
      • Chicago, Illinois
        Northwestern University, Feinberg School of Medicine
      Apr 4, 2013

      An Observational Study on Rituximab Off-label Use for

      Completed
      • Pemphigus
      • +4 more
      • Rituximab (MABTHERA® or RITUXAN®).
      • Toulouse, France
        Service de médecine interne, hôpital Purpan, place du Dr Baylac
      Oct 22, 2012

      Pemphigus Trial in Rouen, (Rituximab)

      Completed
      • Pemphigus
      • Rouen,, Seine maritime,, France
        UH-Rouen
      Sep 12, 2012

      Pemphigus Trial in Petah Tiqva (Rituximab)

      Unknown status
      • Pemphigus
      • Petah Tiqva, Israel
        Bullous diseases clinic, Department of dermatology, Rabin Medica
      Apr 29, 2011

      Pemphigus Trial in Baltimore (cyclophosphamide, filgrastim)

      Completed
      • Pemphigus
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Oct 1, 2008

      Pemphigus Trial in Groningen (dexamethasone (50mg 1dd6, 3 consecutive days/month))

      Completed
      • Pemphigus
      • dexamethasone (50mg 1dd6, 3 consecutive days/month)
      • Groningen, Netherlands
        Department of Dermatology, University Medical Center Groningen
      Aug 29, 2007